MoonLake Immunotherapeutics(MLTX)
$12.87-0.64 (-4.74%)
MLTX
MoonLake Immunotherapeutics earnings date
$12.87
At close:-0.64 (-4.74%)
Want to see MLTX full AI Analyst Report?
MoonLake Immunotherapeutics (MLTX) Q2 2026 Earnings Report
677 Followers
MLTX Q2 2026 EPS Results
- Actual EPS
- -$0.84
- Consensus EPS
- -$0.92
- Beat/Miss
- Beat by +$0.08
- One Year Ago EPS
- -$0.87
MLTX Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/10/2026
- Time
- Before Open
- Conference Call
- Monday, August 10, 2026
MLTX Upcoming Earnings
MoonLake Immunotherapeutics's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MLTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.86- | -0.92 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.83-0.93 | -1.1 | 15.45% (+0.17) | |
| Aug 10, 2026 | 2026 (Q2) | -0.92-0.84 | -0.87 | 3.45% (+0.03) | |
| May 10, 2026 | 2026 (Q1) | -0.89-0.98 | -0.63 | -55.56% (-0.35) | |
| Feb 22, 2026 | 2025 (Q4) | -0.96-0.92 | -0.72 | -27.78% (-0.20) | |
| Nov 05, 2025 | 2025 (Q3) | -0.88-1.10 | -0.56 | -96.43% (-0.54) | |
| Aug 05, 2025 | 2025 (Q2) | -0.74-0.87 | -0.39 | -123.08% (-0.48) | |
| May 12, 2025 | 2025 (Q1) | -0.75-0.63 | -0.22 | -186.36% (-0.41) | |
| Feb 26, 2025 | 2024 (Q4) | -0.62-0.72 | -0.12 | -500.00% (-0.60) | |
| Nov 07, 2024 | 2024 (Q3) | -0.43-0.56 | -0.18 | -211.11% (-0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
